Pentetreotide

Pentetreotide is a diethylenetriaminopentaacetic (DTPA) conjugate of Octreotide. Pentetreotide is an indium-labelled somatostatin analog and can be uesd to nuclear medicine imaging. Somatostatin receptor scintigraphy with Pentetreotide is effective in visualizing neuroendocrine tumors, and its metastasis[1][2].

138661-02-6

12352209

H302-H312-H332

Radionuclide-Drug Conjugates (RDCs)

Antibody-drug Conjugate/ADC Related

Cancer-programmed cell death

Cancer

10 mM in DMSO

O=C([C@@H](NC(C(CSSC[C@@H](C(N[C@H](CO)[C@H](O)C)=O)NC([C@@]([C@H](O)C)([H])NC([C@@](CCCCN)([H])NC1=O)=O)=O)NC([C@H](NC(CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O)=O)CC2=CC=CC=C2)=O)=O)CC3=CC=CC=C3)N[C@@H]1CC4=CNC5=C4C=CC=C5

C63H87N13O19S2

1394.57

P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

[1] Al-Suqri B. 111 In-pentetreotide SPECT CT Value in Follow-up of Patients with Neuro-Endocrine Tumors. Oman Med J. 2014 Sep;29 (5) :362-4.|[2] Masuda R, et al. Concise site-specific synthesis of DTPA-peptide conjugates: application to imaging probes for the chemokine receptor CXCR4. Bioorg Med Chem. 2011 May 15;19 (10) :3216-20.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P2022/

Peptides

No Development Reported

RDC Peptide